YCM
MYGN icon

Yousif Capital Management’s Myriad Genetics MYGN Stock Holding History

Yousif Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,523
Closed -$145K – 1883
2025
Q4 		$145K Sell
25,523
-3,486
-12% -$25.3K ﹤0.01% 1828
2025
Q3 		$210K Sell
29,009
-5,603
-16% -$33.3K ﹤0.01% 1780
2025
Q2 		$184K Hold
34,612
– – ﹤0.01% 1837
2025
Q1 		$307K Sell
34,612
-525
-1% -$6.3K ﹤0.01% 1640
2024
Q4 		$482K Sell
35,137
-669
-2% -$12.3K 0.01% 1492
2024
Q3 		$981K Sell
35,806
-697
-2% -$18.9K 0.01% 1189
2024
Q2 		$893K Sell
36,503
-3,628
-9% -$79.6K 0.01% 1197
2024
Q1 		$856K Sell
40,131
-3,965
-9% -$85.2K 0.01% 1281
2023
Q4 		$844K Buy
44,096
+3,195
+8% +$55.3K 0.01% 1295
2023
Q3 		$656K Sell
40,901
-2,846
-7% -$54.2K 0.01% 1354
2023
Q2 		$1.01M Sell
43,747
-2,063
-5% -$45K 0.01% 1148
2023
Q1 		$1.06M Sell
45,810
-5,950
-11% -$121K 0.01% 1115
2022
Q4 		$751K Sell
51,760
-13,585
-21% -$253K 0.01% 1314
2022
Q3 		$1.25M Sell
65,345
-521
-0.8% -$12K 0.02% 1048
2022
Q2 		$1.2M Sell
65,866
-4,055
-6% -$84.2K 0.02% 1137
2022
Q1 		$1.76M Sell
69,921
-897
-1% -$23K 0.02% 1033
2021
Q4 		$1.96M Buy
+70,818
New +$2.05M 0.02% 984

Other funds holding MYGN

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Yousif Capital Management's MYGN Position: Q1 2026 in Review

Yousif Capital Management sold out of Myriad Genetics (MYGN) in Q1 2026, closing a stake of 25,523 shares — an estimated $145K sold.

Yousif Capital Management first reported a position in MYGN in Q4 2021 and held it in 17 quarters. The position peaked at $1.96M in Q4 2021. 203 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.

  • Yousif Capital Management reported no remaining Myriad Genetics position as of Q1 2026 after selling out during the quarter.
  • Yousif Capital Management sold 25,523 Myriad Genetics shares in Q1 2026, an estimated $145K.
  • Yousif Capital Management first reported a position in Myriad Genetics in Q4 2021 and held it in 17 quarters.
  • Yousif Capital Management's Myriad Genetics position peaked at $1.96M in Q4 2021.
  • 203 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.

Based on Yousif Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.